Literature DB >> 2845380

Effect of nivazol in Nelson's syndrome.

J A Ball1, G Williams, T H Yeo, G F Joplin.   

Abstract

We report the use of nivazol in a patient with Nelson's syndrome. Nivazol was highly effective in reducing ACTH secretion but, contrary to reports of its use in other primates, in our patient nivazol did have systemic glucocorticoid effects.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2845380      PMCID： PMC2428820          DOI： 10.1136/pgmj.64.749.220

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Cushing's syndrome with pituitary tumour and pigmentation.

Authors:  R I BAYLISS
Journal:  Proc R Soc Med       Date:  1959-04

2.  A radioimmunoassay for rat plasma ACTH.

Authors:  L H Rees; D M Cook; J W Kendall; C F Allen; R M Kramer; J G Ratcliffe; R A Knight
Journal:  Endocrinology       Date:  1971-07       Impact factor: 4.736

3.  The pituitary before and after adrenalectomy for Cushing's syndrome.

Authors:  K J Manolas; H M Farmer; H K Wilson; A L Kennedy; G F Joplin; D A Montgomery; T L Kennedy; R B Welbourn
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

4.  Nivazol: a glucocorticoid in rats with only hypothalamic-pituitary-adrenal-inhibiting activity in primates.

Authors:  H P Schane; H R Harding; J E Creange; I Botton; V D Castracane; B W Snyder
Journal:  Endocrinology       Date:  1984-06       Impact factor: 4.736

5.  Effect of nivazol on ACTH secretion by human pituitary corticotrophic tumours in cell culture.

Authors:  E F Adams; M J Ashby; J Burrin; T H Yeo; R Drucker; K Stringer; K Mashiter
Journal:  Clin Endocrinol (Oxf)       Date:  1985-05       Impact factor: 3.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.